Viewing Study NCT00630435


Ignite Creation Date: 2025-12-24 @ 10:08 PM
Ignite Modification Date: 2025-12-25 @ 7:44 PM
Study NCT ID: NCT00630435
Status: COMPLETED
Last Update Posted: 2009-02-04
First Post: 2008-02-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference Formulation
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module